This disclosure is being made further to our intimation dated August 10, 2023, in relation to purported waiver of balance amount of upto GBP 61.85 million(~INR 629 crores), due and payable by Clivedale Overseas Limited (an entity controlled by erstwhile promoters of the Company) to Brenformexa Limited (a subsidiary of the Company). In order to resolve this dispute amicably, the Company, Brenformexa and Clivedale have now mutually agree to refer this dispute to mediation. For more details, please refer attachment.